Fact-checked by Grok 2 weeks ago

Apexification

Apexification is an endodontic procedure used to induce the formation of a calcific barrier at the open of an , nonvital permanent , typically resulting from pulp due to or , thereby facilitating the completion of and preservation of the . The technique was first introduced in the as a non-surgical approach to address the challenges of treating teeth with incomplete root formation, where traditional obturation is difficult due to the absence of an apical constriction. Early methods involved attempts to create an apical stop using materials like or surgical intervention, but these were largely replaced by the use of intracanal medicaments starting with reports by in 1964 and in 1966. Over time, apexification has evolved to prioritize biological induction of deposition rather than mere mechanical sealing. The procedure generally begins with thorough cleaning and disinfection of the root canal to remove necrotic pulp tissue and bacteria, followed by the placement of a biocompatible medicament to stimulate apical barrier formation. Traditionally, calcium hydroxide paste is used as the primary agent, applied in multiple visits over 6 to 24 months (averaging 19 months) until radiographic evidence of a calcified barrier appears, after which the canal is obturated. More recently, mineral trioxide aggregate (MTA), introduced in endodontics in the early 1990s, has become a preferred alternative for one- or few-visit apexification due to its superior sealing properties, biocompatibility, and ability to form a barrier in as little as 1 to 3 visits; bioceramics such as Biodentine offer similar advantages in modern protocols. Apexification boasts high success rates, ranging from 74% to 100%, with effective barrier formation and long-term tooth retention when properly executed. However, it carries risks such as root fractures (28% to 77% incidence) due to the thin, weakened dentinal walls of immature , prompting modern protocols to emphasize reinforcement with bonded composite restorations or fiber posts. Regenerative endodontic procedures, which aim to revitalize the rather than merely seal the apex, are now recommended as preferred alternatives to traditional apexification by the American Association of Endodontists for better root strengthening and continued development in suitable cases.

Background

Definition and Purpose

Apexification is defined as a method to induce a calcified barrier in a root with an open or the continued apical development of an incompletely formed in teeth with necrotic . This procedure is employed in to address the challenges posed by immature where pulp vitality has been lost, typically resulting in halted root maturation. The primary purpose of apexification is to stimulate apical closure or deposition at the root end, thereby creating a seal that prevents apical leakage of materials and facilitates the completion of therapy. It is particularly indicated for non-vital teeth with incomplete formation, often caused by traumatic injuries or deep carious lesions leading to necrosis. By forming this barrier, apexification preserves the tooth structure while enabling effective disinfection and sealing of the system. In anatomical terms, apexification targets the open apex characteristic of immature teeth, frequently described as a blunderbuss canal due to its wide, divergent configuration at the apical end. This morphology arises when ceases prematurely following necrosis, leaving thin dentinal walls that complicate conventional endodontic treatment. Apexification differs from vital pulp therapies, such as apexogenesis, which aim to maintain pulp vitality and promote natural in teeth with partially vital pulps; in contrast, apexification is reserved exclusively for cases involving non-vital pulps where is not feasible.

Historical Development

The concept of apexification emerged in the mid-20th century as a response to the challenges of treating non-vital immature with open apices. The use of for apexification was first introduced by in 1964 and popularized by Alfred L. Frank in 1966, who emphasized thorough canal debridement and medication to minimize contamination while promoting calcific closure over several months. This approach built on earlier observations, such as those by Granath in , but Frank's work demonstrated its potential to facilitate continued root-end formation in pulpless teeth. Subsequent studies in the late further validated and refined these methods. Rule and Winter reported in on root growth and apical repair following pulpal in children, highlighting the possibility of or induced apical even after vital pulp loss. By the and , multi-visit protocols using dominated, typically requiring 6 to 24 months for barrier formation, though variability in closure time and type (e.g., thin versus calcified barriers) was noted in comparative studies. The 1990s marked a pivotal shift toward more efficient one-step procedures with the introduction of (). Developed by Mahmoud Torabinejad and colleagues, was first described in 1993 for its sealing properties, enabling direct apical plug placement without prolonged medication periods. Clinical applications for apexification followed, with Torabinejad and Chivian detailing 's use in 1999 for creating reliable barriers in immature teeth, reducing treatment time and improving predictability compared to traditional methods. Into the 2000s and 2010s, advancements continued with the advent of bioceramics, such as Biodentine and EndoSequence BC, which offered enhanced biocompatibility and faster setting times for apical barriers. Regenerative endodontic procedures—aiming to revitalize tissue and promote natural maturation—gained prominence as preferred alternatives for many cases.

Indications and Diagnosis

Clinical Indications

Apexification is primarily indicated for immature permanent teeth exhibiting pulp necrosis and open apices, where root development remains incomplete, preventing conventional . This procedure is commonly employed in cases resulting from , such as avulsion or luxation injuries, which account for a significant portion of instances (up to 58% in clinical series), as well as caries progression leading to pulp exposure and necrosis, or developmental anomalies like and . The treatment is most frequently applied to , particularly maxillary central and lateral incisors, in pediatric and adolescent patients aged 7 to 18 years, reflecting the prevalence of in this demographic and the stage of . Although predominate (comprising about 75% of cases), apexification is also suitable for immature molars affected by and apical periodontitis, provided the roots are not fully formed. It excludes teeth with complete apical closure, where standard endodontic techniques suffice. Within its scope, apexification is contraindicated for teeth with vital s, as these are better managed through apexogenesis to promote continued root maturation. Active infections, such as unresolved apical periodontitis or abscesses, necessitate prior management before initiating the procedure to ensure favorable outcomes. Representative cases include post-traumatic necrosis in avulsed incisors treated to form an apical barrier, and infected immature molars with periapical lesions where apexification facilitates sealing despite halted root growth.

Diagnostic Criteria

Diagnosis of the need for apexification relies primarily on radiographic evaluation to identify an open apex, characterized by an apical foramen diameter exceeding 1 mm, divergent canal walls presenting a "blunderbuss" appearance, and incomplete root development relative to the contralateral tooth or expected norms for age. Periapical radiographs are the initial imaging modality, revealing these features as indicators of immature permanent teeth with necrotic pulp, often following trauma. Clinical assessment complements through testing, which typically yields a negative response in cases of necrosis, though such tests are less reliable in immature teeth due to incomplete innervation. and evaluate for tenderness suggestive of apical periodontitis, while mobility testing assesses for associated periodontal involvement, particularly in post-traumatic scenarios. If two-dimensional radiographs are inconclusive regarding apical morphology, cone-beam computed tomography (CBCT) provides three-dimensional visualization to confirm the extent of root immaturity and any complex anatomical variations. In suspected infection cases, microbial sampling from the root canal may identify pathogenic bacteria, aiding in confirming pulpal necrosis and periapical involvement. Staging of root immaturity is essential to verify incomplete formation, commonly using Cvek's classification, which categorizes development into five stages based on root length: stage I (<1/2 root length), stage II (1/2 root length), stage III (2/3 root length), stage IV (>2/3 root length but open ), and stage V (closed ). Apexification is indicated primarily for stages I through IV with open apices.

Materials

Calcium Hydroxide

, an alkaline paste primarily composed of Ca(OH)₂, has been the cornerstone material for traditional apexification procedures. It is commonly formulated by mixing the powder with vehicles such as saline, sterile water, , or camphorated monochlorophenol to achieve a workable for intracanal application. The material's high of approximately 12.5 creates an alkaline environment that provides strong antibacterial effects by releasing hydroxyl ions, which disrupt bacterial cell walls and inhibit microbial growth within the . Additionally, calcium hydroxide promotes hard tissue formation at the open apex through an initial inflammatory response that leads to localized , followed by mineralization; calcium ions from the paste and surrounding tissues facilitate the deposition of a calcified barrier over successive applications. In practice, is introduced into the following thorough cleaning and to remove necrotic debris. The paste is typically renewed every 3 to 6 months to counteract its in tissue fluids, which can lead to and reduced effectiveness over time; treatment continues for 6 to 24 months until radiographic confirmation of an apical barrier. This antibacterial property aids in controlling during the extended intrude, while the material's , though a limitation, allows for its periodic refreshment to sustain therapeutic levels. Introduced by in 1964 and popularized by in 1966, emerged as the dominant material for apexification from the through the , establishing itself as the standard for inducing apical closure in non-vital . Success rates for apexification range from 74% to 100% across clinical studies, with outcomes largely contingent on patient for the required multiple visits and material changes. Key limitations include the extended duration, which demands high patient cooperation and increases the risk of complications such as reinfection if appointments are missed. Prolonged exposure to can also weaken the root , elevating the susceptibility to cervical root fractures due to alterations in the tooth's mechanical properties.

Mineral Trioxide Aggregate

Mineral Trioxide Aggregate () is a biocompatible, hydraulic cement primarily composed of derivatives, including tricalcium silicate, dicalcium silicate, , and tetracalcium aluminoferrite, with oxide added as a radiopacifier. This formulation constitutes approximately 75-80% by weight, with oxide comprising 15-20% to enhance visibility on radiographs. Upon mixing with water or moisture, MTA undergoes a that produces gel and , leading to the formation of an hydroxyapatite-like structure that integrates with . Introduced for endodontic applications in 1993 by Torabinejad and colleagues, MTA was initially developed as a root-end filling material but has since become a cornerstone for apexification procedures. In apexification, functions by creating a biocompatible apical that mimics natural formation. The material's high (approximately 12.5 after setting) provides antimicrobial effects, disinfecting the environment and inhibiting . This alkaline environment, combined with the release of calcium ions, promotes the deposition of cementum-like tissue over the material, facilitating barrier formation without inducing significant . Additionally, 's excellent sealing ability prevents microleakage of and fluids, reducing the risk of periapical reinfection. Key advantages of MTA in contemporary apexification include its suitability for single-visit procedures, which shortens treatment duration and improves patient compliance compared to multi-visit calcium hydroxide protocols. Its inherent radiopacity allows for straightforward radiographic assessment of placement and healing progress. MTA also demonstrates superior sealing properties over calcium hydroxide, with lower solubility and enhanced marginal adaptation to dentin walls. Clinically, MTA is applied orthogradely as an apical plug, typically 3-5 mm in thickness, either directly against the canal walls or over an induced blood clot to induce hard tissue bridging. This placement technique ensures hermetic closure while preserving root structure integrity.

Bioceramics and Biodentine

Bioceramics represent a class of advanced bioactive materials used in apexification, particularly as hydraulic cements that set in the presence of moisture to form hydroxyapatite-like structures, promoting effective apical barriers in immature teeth. These materials, such as iRoot BP (also known as BC Putty), are calcium silicate-based and exhibit slight expansion upon setting, which enhances hermetic sealing without generating excessive pressure on surrounding tissues. They release high levels of calcium ions, fostering bioactivity that stimulates mineralization and tissue regeneration, while mimicking natural dentin through the induction of dentin bridge formation and apatite-like mineralized barriers. Biodentine, a tricalcium silicate-based bioceramic, serves as a dentin-like substitute specifically designed for endodontic applications, including the creation of apical plugs in apexification procedures. Its composition includes dicalcium silicate, , oxide, and zirconium oxide as a radiopacifier, with a liquid component of and a water-soluble that accelerates . Biodentine achieves a fast setting time of approximately 12 minutes, enabling efficient placement and reducing the risk of contamination or washout during single-visit treatments. This bioactivity supports and apical barrier formation by releasing calcium ions and transforming growth factor-beta 1 (TGF-β1), which penetrate tubules to promote tertiary synthesis and odontoblastic . Compared to (), bioceramics like Biodentine and iRoot BP offer advantages in clinical handling due to their putty-like consistency and ease of preparation, allowing for precise application without specialized equipment. They exhibit minimal risk of tooth discoloration, a common issue with , and are generally more cost-effective for routine use in . Additionally, these materials promote the differentiation of odontoblast-like cells, enhancing deposition and long-term root strengthening. Since the early 2010s, bioceramics have gained prominence in , particularly for single-visit s in immature permanent teeth, driven by their , rapid setting, and high success rates in promoting root-end closure.

Traditional Multi-Visit

The traditional multi-visit for utilizes as an intracanal medicament to induce the formation of a calcific apical barrier in immature permanent teeth with open apices, typically requiring several appointments over an extended period. This method, established as the conventional approach since the mid-20th century, aims to disinfect the system and stimulate deposition at the before completing . The procedure begins with the initial visit, where local anesthesia is administered if necessary, followed by isolation of the tooth using a rubber dam to maintain an aseptic field. An access cavity is prepared to allow straight-line entry into the root canal, and the working length is determined radiographically, usually set 1 mm short of the radiographic apex using an apical file such as a #15 or #20 K-file. The remaining pulp tissue is extirpated, and the canal is debrided with hand or rotary instruments, followed by copious irrigation with 2.5-5.25% sodium hypochlorite (NaOCl) to remove debris and eliminate bacteria. After drying the canal with paper points, a calcium hydroxide paste—typically mixed with a vehicle like sterile water, saline, or glycerin—is introduced into the canal using a lentulo spiral or syringe, condensed to the apical terminus with a plugger, and sealed coronally with a temporary restorative material such as glass ionomer cement to prevent leakage. This initial placement allows for initial disinfection and the onset of the inductive process. Subsequent visits occur at intervals of 3-6 months, during which periapical radiographs are taken to evaluate progress toward apical barrier formation. If radiographic evidence shows incomplete barrier development or persistent radiolucency, the temporary restoration is removed, the canal is re-irrigated with NaOCl, and fresh paste is repacked to the apex, with the coronal seal reapplied. The total duration of this inductive phase varies, commonly ranging from 6 to 24 months, depending on factors such as the initial apical diameter, patient age, and the extent of prior ; in some cases, complete barrier formation may take up to 30 months. Patient compliance is essential during this period, as multiple visits are required, and interim coronal restorations must be maintained to avoid reinfection or fracture. Barrier formation is confirmed radiographically by the appearance of a calcific bridge at the , often appearing as a or dome-shaped structure, supplemented by clinical testing where a point or file is gently advanced to assess for a solid "stop" without apical , hemorrhage, or sensitivity. Once confirmed, the canal is obturated in a final visit using via lateral condensation or warm vertical compaction techniques, ensuring the material does not exceed the barrier, followed by a permanent coronal . Any postoperative discomfort is managed with over-the-counter analgesics and antibiotics if signs of arise, emphasizing the importance of follow-up to monitor healing.

Single-Visit Protocol

The single-visit apexification protocol represents a modern approach to treating immature permanent teeth with open apices and necrotic pulps, utilizing bioactive materials such as (MTA) or bioceramics to create an artificial apical barrier in a single appointment, thereby enabling immediate obturation. This method contrasts with traditional techniques by leveraging the rapid sealing and biocompatible properties of these materials to form a stable plug without requiring multiple visits for barrier induction. Preparation begins with , rubber dam isolation, and access cavity preparation to expose the system. The canal is then thoroughly cleaned and shaped using hand or rotary instruments, irrigated copiously with 2.5-5.25% (NaOCl) to remove necrotic tissue and debris, followed by 17% (EDTA) to eliminate the smear layer, and a final rinse with saline or to disinfect. The working length is determined radiographically, typically 1-2 mm short of the radiographic apex, and the canal is gently dried with sterile paper points to avoid over-drying the periapical tissues. To prevent extrusion of the apical plug material, a provisional apical stop of 3-4 mm is created using a resorbable sponge or matrix, positioned at the desired apical level and confirmed radiographically. Placement of the apical plug involves orthograde delivery of or a bioceramic material, such as Biodentine or EndoSequence Root Repair Material, mixed to a putty-like consistency. A 3-5 mm thick plug is incrementally deposited using a specialized carrier (e.g., Dovgan or Micro Apical Placement system) and condensed against the apical stop with endodontic pluggers sized one size smaller than the apical preparation, ensuring adaptation to the canal walls without . Radiographic confirms proper positioning, and the plug is moistened coronally with a sterile water-dipped paper point or cotton pellet to facilitate setting; typically requires 2-4 hours for initial hardening, while bioceramics like Biodentine set in approximately 12 minutes due to their calcium silicate-based hydration. A temporary restoration, such as , is placed over the unset portion if needed. If the barrier has sufficiently set during the appointment, immediate follows by filling the coronal and middle portions of the canal with and a biocompatible sealer (e.g., AH Plus) using lateral compaction or a warm vertical technique, followed by a core buildup with composite resin and final coronal to restore and . This protocol offers several advantages, including reduced number of patient visits, which minimizes the risk of reinfection from coronal leakage or loss of temporary fillings, and makes it particularly suitable for non-compliant patients or those in remote areas. Additionally, the immediate restoration enhances the structural integrity of the thin dentinal walls, reducing fracture susceptibility compared to prolonged multi-visit approaches.

Outcomes and Follow-Up

Success Rates and Criteria

Success in apexification is defined as radiographic evidence of apical closure or the formation of a calcific barrier within 12-24 months, alongside the absence of clinical symptoms such as pain or swelling and resolution of periapical pathology. This criteria emphasizes both clinical stability and radiographic healing, typically assessed through periapical radiographs showing reduced radiolucency and barrier development. Reported success rates for apexification vary by material and protocol. Traditional multi-visit apexification using achieves overall success rates of 74-100%, based on clinical studies and reviews evaluating clinical and radiographic outcomes. In contrast, single-visit apexification with (MTA) demonstrates rates of 90-100% for radiographic barrier formation and clinical resolution, as evidenced by systematic reviews. Bioceramic materials like Biodentine show comparable success rates of 87-93%. These rates reflect the efficiency of and bioceramics in promoting rapid barrier formation compared to the longer duration required for . Several factors influence apexification outcomes. Success tends to be higher in due to simpler root morphology and better access, though direct comparisons to molars are limited. Effective initial infection control, including thorough disinfection and reduction of periapical index (PAI) scores preoperatively, significantly enhances healing and reduces the risk of persistent pathology. Long-term studies indicate robust survival following apexification. A of U.S. dental claims data reported tooth survival rates of 86% at 5 years post-treatment, with functional retention achieved without in the majority of cases. These outcomes underscore the procedure's reliability for preserving teeth over extended periods, particularly when combined with appropriate restorative measures.

Monitoring and Long-Term Care

Following apexification, patients undergo a structured follow-up to assess treatment outcomes, typically involving radiographic evaluations at 6, 12, and 24 months post-treatment, alongside clinical examinations for signs of , swelling, , and secondary caries. These assessments help track periapical healing and root integrity without requiring pulp vitality testing, as the procedure addresses non-vital immature teeth. Radiographic signs of success include progressive thickening of the apical barrier and of any pre-existing periapical radiolucency, while failure is indicated by persistent or worsening radiolucency, root fracture, or lack of barrier formation. Clinical success is confirmed by the absence of symptoms such as tenderness to percussion or during these evaluations. Long-term care emphasizes regular dental check-ups every 6 to 12 months to monitor for any changes, with periodic of coronal restorations to maintain an intact seal against bacterial ingress. If reinfection occurs, evidenced by new symptoms or radiographic , retreatment via nonsurgical endodontic revision or apical may be necessary to address the issue. Patient education plays a key role in sustaining outcomes, focusing on the importance of meticulous practices, including brushing, flossing, and use, to prevent coronal leakage that could compromise the apical barrier.

Complications and Alternatives

Potential Complications

Apexification procedures carry several potential risks, primarily due to the immature nature of the treated teeth and the materials involved. One common complication is incomplete or irregular apical barrier formation, which can occur in traditional calcium hydroxide-based methods because of variability in deposition and the need for multiple applications to achieve . This issue arises from factors such as persistent or inconsistent material response, potentially leading to challenges in subsequent . Additionally, the thin dentinal walls of immature increase susceptibility to , particularly in the cervical or apical regions, as the procedure does not promote further root thickening. Material-specific complications further contribute to risks. Long-term use of can weaken the by denaturing and reducing microhardness through its high , thereby compromising the structural integrity of the root and elevating fracture risk after prolonged exposure. In contrast, (MTA) may cause beyond the during placement, resulting in periapical or if excessive amounts are displaced. MTA also poses a risk of coronal discoloration, especially with gray variants, due to material oxidation and interaction with or fluids, affecting aesthetics in anterior teeth. Infection-related complications include reinfection of the , often stemming from coronal leakage or inadequate sealing during the multi-visit process, which allows bacterial ingress and undermines barrier formation. Persistent or recurrent apical periodontitis can also arrest any potential for further root development, exacerbating the tooth's vulnerability. Early detection of these issues through regular radiographic follow-up is essential for timely intervention and prevention of progression to more severe outcomes, such as .

Alternative Treatments

Apexogenesis represents a vital pulp therapy approach for immature permanent teeth where the pulp remains viable despite injury from caries or trauma, enabling the continuation of natural root development and apical closure. This procedure involves partial removal of inflamed coronal pulp tissue, hemostasis, and placement of a biocompatible material such as mineral trioxide aggregate (MTA) or calcium hydroxide, followed by a sealed restoration to maintain vitality. It is the preferred initial intervention over apexification when reversible pulpitis is diagnosed, as it preserves the tooth's innate ability to complete physiological maturation, potentially strengthening the root against future fractures. Regenerative endodontic procedures (REPs), including and revitalization techniques, offer a biologically driven to apexification for necrotic teeth with open apices, aiming to regenerate vital tissues within the system. These protocols, outlined in the American Association of Endodontists (AAE) clinical considerations since 2010, typically involve two visits: initial canal disinfection using irrigation and a triple antibiotic paste (, , and ) to eliminate , followed by induced via beyond the to form a natural blood clot scaffold, and coronal sealing with or bioceramics. Unlike apexification, which induces a static barrier without pulp regeneration, REPs promote continued root lengthening and thickening in approximately 77-80% of cases, with overall success rates exceeding 90% for elimination of symptoms and periapical healing. Clinical studies indicate superior outcomes in root maturation compared to traditional apexification, particularly in teeth with severe developmental deficiencies. For cases where apexification fails due to persistent , inadequate barrier formation, or structural compromise, extraction followed by prosthetic replacement with a emerges as a last-resort option. This approach contrasts with apexification's emphasis on natural tooth retention, which supports long-term periodontal health and avoids the functional and aesthetic challenges of implants in growing patients. Emerging trends in managing open-apex teeth focus on advanced regenerative strategies incorporating bioactive scaffolds and therapies to overcome limitations in current protocols. Bioactive scaffolds, such as collagen-based hydrogels or matrices, provide a three-dimensional framework that mimics the , facilitating and when combined with growth factors. cells from the dental (DPSCs) or apical (SCAPs) have demonstrated potential in preclinical and early clinical studies up to 2025 for inducing dentin bridge formation and root elongation, with systematic reviews confirming efficacy in endodontic regeneration while noting challenges in clinical translation such as immune compatibility and standardization. enabling customized delivery to enhance integration. These cell-based approaches, while still investigational, show promise for higher predictability in compared to conventional REPs, though challenges like immune compatibility and standardization persist.